Category
Bromazepam
CAS Number
41526-21-0
Molecular Formula
C₁₄H₁₀BrClN O₂
Molecular Weight
353.6 g/mol
Synonym

 N-[4-Bromo-2-(pyridin-2-ylcarbonyl)phenyl]-2-chloroacetamide ; N-(4-Bromo-2-picolinoylphenyl)-2-chloroacetamide; 2-(2-Chloroacetamido-5-bromobenzoyl)pyridine; 2-[2-(2-Chloroacetamido)-5-bromobenzoyl]pyridine; Bromazepam EP Impurity B ;

Keywords
Fine Chemicals
Psychotropic Substances
Aromatics
Amines
Pharmaceutical Standards
Heterocycles
Intermediates
Impurities manufacturer and Suppliers in Hyderabad india
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

For comprehensive impurity assessment and regulatory compliance studies, Manasa Life Sciences provides Bromazepam Impurity B, Commonly known as Bromazepam EP Impurity B and chemically identified as N-(4-Bromo-2-picolinoylphenyl)-2-chloroacetamide. This specialized reference material possesses a cas no of 41526-21-0, molecular formula of C₁₄H₁₀BrClN₂O₂ and a molecular weight of 353.6 g/mol.

Widely applied in quality control testing, stability-indicating studies, analytical method validation, and impurity characterization, the standard enables accurate monitoring of impurity levels and degradation behavior in Bromazepam-related products. Compatibility with HPLC, LC-MS, Mass Spectrometry, and NMR methodologies makes it an essential tool for pharmaceutical analysis. Supported by detailed COA, SDS/MSDS, and GMP/GDP documentation, the product is supplied globally to meet the needs of API manufacturers, CROs, and research laboratories requiring reliable analytical standards.